Discovery of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (nelotanserin) and related 5-hydroxytryptamine2A inverse agonists for the treatment of insomnia. (Q34097763)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (nelotanserin) and related 5-hydroxytryptamine2A inverse agonists for the treatment of insomnia. |
scientific article |
Statements
Discovery of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (nelotanserin) and related 5-hydroxytryptamine2A inverse agonists for the treatment of insomnia (English)
Stephen R Morairty
Bradley R Teegarden
Hongmei Li
Honnappa Jayakumar
Sonja Strah-Pleynet
Susan D Selaya
Naomi Kato
Katie H Elwell
Jarrod Davidson
Karen Cheng
Hazel Saldana
John M Frazer
Kevin Whelan
Jonathan Foster
Stephan Espitia
Robert R Webb
Nigel R A Beeley
William Thomsen
Hussien A Al-Shamma